These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1295 related articles for article (PubMed ID: 32627758)

  • 1. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
    Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
    J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 4. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
    Sariol A; Perlman S
    Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2: A New Song Recalls an Old Melody.
    Subbarao K
    Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines: Knowing the unknown.
    Lv H; Wu NC; Mok CKP
    Eur J Immunol; 2020 Jul; 50(7):939-943. PubMed ID: 32437587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.
    Gupta T; Gupta SK
    Int Immunopharmacol; 2020 Sep; 86():106717. PubMed ID: 32585611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for COVID-19: The current state of play.
    Koirala A; Joo YJ; Khatami A; Chiu C; Britton PN
    Paediatr Respir Rev; 2020 Sep; 35():43-49. PubMed ID: 32653463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
    Vignesh R; Shankar EM; Velu V; Thyagarajan SP
    Front Immunol; 2020; 11():586781. PubMed ID: 33101320
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune-mediated approaches against COVID-19.
    Florindo HF; Kleiner R; Vaskovich-Koubi D; Acúrcio RC; Carreira B; Yeini E; Tiram G; Liubomirski Y; Satchi-Fainaro R
    Nat Nanotechnol; 2020 Aug; 15(8):630-645. PubMed ID: 32661375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches and Challenges in SARS-CoV-2 Vaccine Development.
    Dagotto G; Yu J; Barouch DH
    Cell Host Microbe; 2020 Sep; 28(3):364-370. PubMed ID: 32798444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
    Zayed H
    Front Immunol; 2020; 11():2051. PubMed ID: 32922408
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
    Prompetchara E; Ketloy C; Palaga T
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):1-9. PubMed ID: 32105090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
    Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
    Front Immunol; 2020; 11():2059. PubMed ID: 33013871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.
    Khalaj-Hedayati A
    J Immunol Res; 2020; 2020():7201752. PubMed ID: 32695833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
    Usmani SS; Raghava GPS
    Front Immunol; 2020; 11():561851. PubMed ID: 33133071
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronavirus reinfections: three questions scientists are asking.
    Ledford H
    Nature; 2020 Sep; 585(7824):168-169. PubMed ID: 32887957
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
    De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
    Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
    Saad-Roy CM; Wagner CE; Baker RE; Morris SE; Farrar J; Graham AL; Levin SA; Mina MJ; Metcalf CJE; Grenfell BT
    Science; 2020 Nov; 370(6518):811-818. PubMed ID: 32958581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.